PSEUDOXANTHOMA ELASTICUM
Clinical trials for PSEUDOXANTHOMA ELASTICUM explained in plain language.
Never miss a new study
Get alerted when new PSEUDOXANTHOMA ELASTICUM trials appear
Sign up with your email to follow new studies for PSEUDOXANTHOMA ELASTICUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First treatment tested for babies with deadly artery hardening disease
Disease control Recruiting nowThis study is testing a new enzyme replacement therapy called INZ-701 in infants with rare genetic disorders that cause dangerous calcium buildup in arteries and weak bones. The main goal is to check if the treatment is safe and well-tolerated in babies under one year old. Resear…
Matched conditions: PSEUDOXANTHOMA ELASTICUM
Phase: PHASE1 • Sponsor: Inozyme Pharma • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Eye scans could unlock clues for rare, incurable disease
Knowledge-focused Recruiting nowThis study aims to understand a rare genetic disease called pseudoxanthoma elasticum (PXE) by looking at blood flow in the back of the eye. Researchers will compare detailed eye scans from 60 healthy volunteers to scans from 60 patients with PXE. The goal is to see if changes in …
Matched conditions: PSEUDOXANTHOMA ELASTICUM
Phase: NA • Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC